Zomedica Corp. (ZOM)

0,1452 +0,0032 (+2,25%) Al cierre: 04:00PM EDT

Zomedica Corp.

100 Phoenix Drive
Suite 190
Ann Arbor, MI 48108
United States
734 369 2555
https://www.zomedica.com

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 144

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Larry C. Heaton II	President, CEO & Director	651,4k	N/A	1957
Mr. Peter L. Donato BSBA, M.B.A.	Chief Financial Officer	311,01k	N/A	1970
Ms. Kristin Domanski	Vice President of Human Resources	N/A	N/A	N/A
Mr. Greg Blair	Senior Vice President of Business Development & Strategic Planning	N/A	N/A	N/A
Mr. Robert W. DiMarzo	Consultant	291,2k	N/A	1957

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

Gobierno corporativo

El ISS Governance QualityScore de Zomedica Corp., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.